C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.665 AUD
-0.3%
Market Closed
Updated:
May 15, 2024
Cyclopharm Ltd
Interest Income Expense
|
Cyclopharm Ltd
Interest Income Expense Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Interest Income Expense
-AU$30.6k
|
CAGR 3-Years
67%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
25%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Interest Income Expense
AU$1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Cochlear Ltd
ASX:COH
|
Interest Income Expense
-AU$2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
25%
|
CAGR 10-Years
12%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Interest Income Expense
AU$243.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Interest Income Expense
-AU$35.3k
|
CAGR 3-Years
-289%
|
CAGR 5-Years
-137%
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Interest Income Expense?
Interest Income Expense
-30.6k
AUD
-30.6k
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Interest Income Expense amounts to -30.6k AUD.
What is Cyclopharm Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
25%
25%
Over the last year, the Interest Income Expense growth was 78%. The average annual Interest Income Expense growth rates for Cyclopharm Ltd have been 67% over the past three years , -3% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
